...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Poster
3
Jun 15, 2020 04:12PM

Same abstract that we discussed mid-May. Poster is not up yet and probably won't be until 6/22.

 

Share
New Message
Please login to post a reply